BRIEF-Accendra Health, Inc Q2 Adjusted EBITDA USD 60.1 Million Vs. IBES Estimate USD 61.3 Million
ACH•Second-quarter results
Aug. 10 (Reuters) - Accendra Health, Inc. Q2 adjusted EBITDA was USD 60.1 million versus the IBES estimate of USD 61.3 million.
- Q2 net income: USD -89.07 million
- Q2 revenue: USD 613.2 million vs. IBES estimate USD 627.3 million
